MedPath

HYDRALAZINE HYDROCHLORIDE INJECTION, USP

HYDRALAZINE HYDROCHLORIDE INJECTION, USP

Approved
DIN Number

02537699

Drug Class

Human

Market Date

Oct 7, 2024

Company
HC

eugia pharma inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02537699
AIG Number0107444005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C02DB02 HYDRALAZINE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification24:08.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

HYDRALAZINE HYDROCHLORIDEActive
Strength: 20 MG / ML
Monograph: HYDRALAZINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.